Dextrue 25 Infusion contains Dextrose 25% w/v, a concentrated hypertonic intravenous solution used for hydration, energy supplementation, and as a carrier for medications. It provides rapid glucose supply to patients needing additional caloric intake or correction of severe hypoglycemia.
This high-strength infusion is widely used in hospital and critical care settings, including ICU, surgical, and oncology supportive care units. Its hypertonic formulation ensures effective energy delivery, improved patient metabolism, and compatibility with other IV medications under medical supervision.
For distributors, hospital suppliers, and institutional wholesalers, Dextrue 25 Infusion is a high-demand IV hypertonic solution, regularly utilized in emergency care, specialized therapy units, and intensive care wards. Continuous clinical application drives consistent procurement and steady market demand.
Adding Dextrue 25 Infusion to your product portfolio enhances your hospital care and energy supplementation segment, opening opportunities in institutional supply, hospital procurement, government tenders, export consignments, and third-party manufacturing. Its essential role in patient hydration and energy management makes it a profitable and strategically important product for pharmaceutical distributors.